Performance Measures for Adults with Peripheral Artery Disease ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery.

Slides:

Advertisements

Similar presentations

Guidelines for the Primary Prevention of Stroke. A Guideline for Healthcare Professionals From the American Heart Association & American Stroke Association.

Advertisements

ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning” A Report of the American College of Cardiology Foundation Task Force on Clinical.

© 2010, American Heart Association. All rights reserved. Are Quality Improvements Associated with the GWTG-Coronary Artery Disease (GWTG-CAD) Program Sustained.

2013 ACCF/AHA/SCAI Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures A Report of the American College of Cardiology.

Summary Prepared by Melvyn Rubenfire, MD

© 2008, American Heart Association. All rights reserved. AHA 2008 Resistant Hypertension: Diagnosis, Evaluation, and Treatment Slide Set David A. Calhoun,

Peripheral Arterial Disease :PAD. Introduction PAD caused by atherosclerotic occlusion of arteries to legs Prevalence 12% and increases to 20% if persons.

Peripheral Arterial Disease >Increasing Awareness >What is PAD >Risk factors >Symptoms of PAD >Screening & Treatment Options.

Medical Student Small Group Discussion Topics

Guiding Principles for the Care of People With or at Risk for Diabetes

Upper vs. Lower Body Aerobic Training in Patients with Claudication Diane Treat-Jacobson, PhD, RN Assistant Professor of Nursing Center for Gerontological.

Copyright © 2009, Society for Vascular Surgery ®. All rights reserved. Your Vascular Health is a Matter of Life and Limb.

CONTROLLING YOUR RISK FACTORS Taking the Steps to a Healthy Heart.

2011 ACCF/AHA Focused Update of the Management of Patients With Peripheral Artery Disease Guideline (Updating the 2005 Guideline) Developed in Collaboration.

Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly Findings From the Get With the Guidelines Quality-

Ulcerations Due to Peripheral Vascular Disease

PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.

Presented by Michelle Sitto. The term peripheral vascular disease is commonly used to refer to peripheral artery disease (PAD), meaning narrowing or occlusion.

Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?

Lower Extremity Venous Disease: Peripheral Venous Insufficiency

Presented by TaSheva Davis, BSN, RN Peripheral Arterial Disease.

A guide for healthcare professionals Measuring Blood Pressure at Home Michigan Department of Community Health Heart Disease and Stroke Prevention Unit.

Epidemiology, Risk Factors, Diagnosis and Intervention of Abdominal Aortic Aneurysms By, Sultan O Al-Sheikh.

Chapter 17 Nursing Diagnosis

Life Line Screening: Age and gender specific prevalence of AAA, PAD, carotid stenosis and AF and their associations with smoking Sarah Lewington CTSU,

Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.

Special Report Peripheral Arterial Disease: Lack of Awareness in Canada The First Canadian P.A.D. Public Awareness Survey Peripheral Arterial Disease:

December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?

Demonstration of a Process- Outcome Link for Smoking Cessation Melissa M. Farmer, PhD 1,2 Elizabeth M. Yano, PhD 1,2 Brian S. Mittman, PhD 1,2 Scott E.

The Effect of Quality Improvement on Racial Disparities in Diabetes Care Thomas D. Sequist, MD MPH Alyce S. Adams, PhD Fang Zhang, MS Dennis Ross-Degnan,

Post-Surgical Care for the Individual With PAD: A Shared Responsibility to Sustain Life and Limb.

SHAWN KISE, BSN, RN May 14 th 2012 Wright State University CVD IN MIDDLE AGE MEN.

Ross Milner, MDUniversity of Chicago Mark Russo, MD, MS Center for Aortic Diseases.

Venous Doppler Remains primary modality for assessing deep venous thrombosis of upper & lower extremities Diagnostic Criteria for DVT: Most reliable is.

Acute Stroke: Principles of Modern Management A program of the American Academy of Neurology The AAN Acute Stroke Management courses are supported in part.

The IC 3 (Improving Continuous Cardiac Care) - PINNACLE Program: A Report of the first 14,000+ Patients Paul S. Chan, MD MScWilliam J. Oetgen, MD Donna.

Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.

VA National Center for Health Promotion and Disease Prevention Using USPSTF Recommendations in VHA Clinical Practice Linda Kinsinger, MD, MPH Chief Consultant.

Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,

ACC/AHA 2006 guidelines on the management of PAD.

Pathophysiology BMS 243 Vascular Diseases Lecture IV Dr. Aya M. Serry

A Multicentre Audit of Best Medical Therapy for Aneurysm Surveillance Patients P Stather, N Dattani, D Sidloff On Behalf of VERN.

AA-1-1 Mark B. Kreston President, Worldwide Consumer Medicines 7asdf.

© 2008, American Heart Association. All rights reserved. AHA/ACC/HRS Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying.

Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.

Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;

Incidence of Abnormal Ankle-Brachial Index in Diabetic Patients Asymptomatic of Arteriosclerotic Vascular disease Brintha Vasagar, MD, MPH, Katee Castleman,

Peripheral Vascular Disease

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease Developed in Collaboration with.

Patients with abdominal aortic aneurysm: Are we missing the opportunity for cardiovascular risk reduction? G.M. Lloyd, MRCS, J.D. Newton, MRCP, M.G.A.

AAA, abdominal aortic aneurysm; ABIs, ankle-brachial index; GI, gastrointestinal; GU, genitourinary; MRI, magnetic resonance imaging; PAD, peripheral arterial.

Late survival in abdominal aortic aneurysm patients: The role of selective myocardial revascularization on the basis of clinical symptoms Martha M. Reigel,

Cholesterol practice questions

Peripheral Arterial Disease

Post-Surgical Care for the Individual With PAD

A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease.

ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization Manesh R. Patel, MD, FACC, Steven.

A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease.

Warren J. Gasper, MD, Christopher D

Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories Jeffrey S. Berger, MD, MS, Judith Hochman,

Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories Jeffrey S. Berger, MD, MS, Judith Hochman,

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease Glenn N. Levine, MD, FACC, FAHA,

Antithrombotic Therapy in PAD

Life Line Screening is coming to Our Lady of Fatima Church

Abdominal aortic aneurysm: A general defect in the vasculature with focal manifestations in the abdominal aorta? Björn Sonesson, MD, PhD, Flemming Hansen,

Endovascular Live Case Mount Sinai Hospital, NY

Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China Yao He, MD, PhD, Yong Jiang,

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

Tissue (muscle) oxygen saturation (StO2): A new measure of symptomatic lower- extremity arterial disease Anthony J Comerota, MD, Richard C Throm, BA,

Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass.

Presentation transcript:

Performance Measures for Adults with Peripheral Artery Disease ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.

Jeffrey W. Olin, DO, FACC, FAHA, Chair David E. Allie, MD Michael Belkin, MD Robert O. Bonow, MD, MACC, FAHA Donald E. Casey, Jr, MD, MPH, MBA, FACP Mark A. Creager, MD, FACC, FAHA Thomas C. Gerber, MD, PhD, FACP, FACC, FAHA Alan T. Hirsch, MD, FACC, FAHA Michael R. Jaff, DO, FACC, FAHA John A. Kaufman, MD, FAHA Writing Committee Curtis A. Lewis, MD, MBA, JD Edward T. Martin, MD, FACC, FACP, FAHA Louis G. Martin, MD, FSIR Peter Sheehan, MD Kerry J. Stewart, EDD, FAACVPR, FAHA, FACSM Diane Treat-Jacobson, PhD, RN, FAHA Christopher J. White, MD, FACC, FAHA, FSCAI Zhi-Jie Zheng, MD, PhD ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.

Peripheral arterial disease refers to a diverse group of disorders that lead to progressive stenosis or occlusion, or aneurysmal dilation of the aorta and its noncoronary branch arteries, including the: carotid upper extremity visceral lower extremity arterial branches PAD Definition ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.

PAD Prevalence Approximately 8 million persons in the United States are afflicted with PAD. Prevalence of PAD is approximately 12% of the adult population, with men being affected slightly more than women. Age dependent - Almost 20% of adults over the age of 70 years have PAD. ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.

PAD PM This measure set defines six Dimensions of Care for which each measure fits at least one: –Risk Assessment –Diagnostics –Patient Education –Treatment –Self-Management/Compliance –Monitoring of Disease Status ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.

PAD PM There were 37 potential measures initially advanced for full specification to assess their suitability as performance measures. Those potential measures were eventually reduced to 7 final performance measures and 2 test measures. ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.

PAD PM The seven considered suitable for pay for performance, physician ranking, or public reporting programs are as follows: 1. Ankle brachial index 2. Cholesterol-lowering medications 3. Smoking cessation 4. Antiplatelet therapy 5. Supervised exercise 6. Lower extremity vein bypass graft surveillance 7. Monitoring of abdominal aortic aneurysms (AAA) ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.

PAD PM The two test measures designated for internal QI programs only are T-1. Vascular review of systems for lower extremity PAD T-2. PAD at risk population pulse examination ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.

PAD PM Please see full text version for the following related to each measure: Numerator Denominator Period of Assessment Sources of Data Rationale Clinical Recommendations Attribution/Aggregation Method of Reporting Challenges to Implementation ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.

Summary 1.Seven proposed measures for public reporting/accountability. 2.These measures will be submitted to the National Quality Forum for 2013 call for CV measures because not sufficient testing data available for 2010 call. 3.Two proposed measures are for internal QI only (will not be submitted to NQF). 4.Full text contains sample prospective data collection flow sheet. ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.

Jeffrey W. Olin, DO, FACC, FAHA, Chair David E. Allie, MD Michael Belkin, MD Robert O. Bonow, MD, MACC, FAHA Donald E. Casey, Jr, MD, MPH, MBA, FACP Mark A. Creager, MD, FACC, FAHA Thomas C. Gerber, MD, PhD, FACP, FACC, FAHA Alan T. Hirsch, MD, FACC, FAHA Michael R. Jaff, DO, FACC, FAHA John A. Kaufman, MD, FAHA Writing Committee Curtis A. Lewis, MD, MBA, JD Edward T. Martin, MD, FACC, FACP, FAHA Louis G. Martin, MD, FSIR Peter Sheehan, MD Kerry J. Stewart, EDD, FAACVPR, FAHA, FACSM Diane Treat-Jacobson, PhD, RN, FAHA Christopher J. White, MD, FACC, FAHA, FSCAI Zhi-Jie Zheng, MD, PhD ACCF/AHA/ACR/SCAI/SIR/ SVM/SVN/SVS Performance Measures for Adults with Peripheral Artery Disease ©2010 American Heart Association, Inc. All rights reserved.